Several studies have identified the overexpression of Ep-CAM as related to processes of initiation, tumor progression, metastasis and poor outcome in pancreatic, gallbladder, gastric and nasopharyngeal cancer (11,12). This evidence concerns the gene EPCAM and neoplasm.